Evamenol® Active (Ointment) Instructions for Use
Marketing Authorization Holder
Moscow Pharmaceutical Factory CJS (Russia)
ATC Code
M02AX (Other drugs for topical application for joint and muscle pain)
Active Substances
Camphor (Ph.Eur. European Pharmacopoeia)
Levomenthol (Rec.INN WHO registered)
Eucalyptus oil (BP British Pharmacopoeia)
Dosage Form
| Evamenol® Active | Ointment for external use: 30 g tube |
Dosage Form, Packaging, and Composition
Ointment for external use white or white with a yellowish tint, homogeneous, with a characteristic odor.
| 100 g | |
| Levomenthol (L-menthol)* | 18 g |
| Camphor (Synthetic camphor) | 10 g |
| Eucalyptus globulus leaf oil (Eucalyptus oil) | 10 g |
* or Mentha piperita leaf oil (Peppermint oil) (with L-menthol content 70%) – 25.75 g.
Excipients : Clove flower oil – 1 g, Hard paraffin – 30.5 g, Petroleum jelly – up to 100 g.
Excipients : Clove flower oil – 1 g, Hard paraffin – 26 g, Petroleum jelly – up to 100 g.
30 g – aluminum tubes (1) – cardboard packs.
Clinical-Pharmacological Group
Drug with local irritant and analgesic action
Pharmacotherapeutic Group
Local irritant of natural origin
Pharmacological Action
A combined herbal preparation. Its action is due to reflex reactions associated with the irritation of sensitive nerve endings of the skin and subcutaneous structures.
It exerts a locally irritating (“counterirritant”), weak local anesthetic effect.
Indications
As a “counterirritant”, local analgesic agent for neuralgia, myalgia, arthralgia, myositis.
ICD codes
| ICD-10 code | Indication |
| M25.5 | Pain in joint |
| M60 | Myositis |
| M79.1 | Myalgia |
| M79.2 | Neuralgia and neuritis, unspecified |
| ICD-11 code | Indication |
| 8E4A.1 | Paraneoplastic or autoimmune diseases of the peripheral or autonomic nervous system |
| FB30 | Infectious myositis |
| FB32 | Other specified disorders of muscle |
| FB3Z | Disorder of muscle, unspecified |
| FB56 | Specified soft tissue diseases, not elsewhere classified |
| FB56.0 | Granuloma of soft tissue due to foreign body, not elsewhere classified |
| FB56.2 | Myalgia |
| ME82 | Pain in joint |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Apply the ointment externally only to intact skin.
Use a small amount of ointment, approximately the size of a pea, for each application site.
Rub the ointment into the painful area using light, massaging movements until fully absorbed.
Apply the ointment two to three times daily, depending on the intensity of pain.
Allow a minimum interval of several hours between applications.
Do not apply the ointment under occlusive dressings or bandages.
Limit the total duration of continuous use to seven days for acute pain.
Discontinue use and consult a physician if symptoms persist or worsen after one week of treatment.
Seek immediate medical advice if excessive skin irritation, redness, or swelling occurs.
Avoid contact with eyes, mucous membranes, and open wounds.
Wash hands thoroughly with soap and water immediately after each application.
Adverse Reactions
Possible allergic reactions, burning, tingling, sensation of cold at the site of ointment application.
Contraindications
Dermatological diseases; impaired skin integrity at the site of intended application of the drug; children under 12 years of age; hypersensitivity to the drug components.
Use in Pregnancy and Lactation
Use of the drug during pregnancy and breastfeeding is possible considering the intended benefit for the mother and the potential risk for the fetus/child.
Pediatric Use
Use of the drug is contraindicated in children under 12 years of age.
Special Precautions
After applying the ointment, wash hands thoroughly with soap and water.
Avoid getting the ointment into the eyes and on mucous membranes.
In case of contact with eyes and mucous membranes, rinse them abundantly with water and consult a doctor.
Effect on ability to drive vehicles and mechanisms
The drug does not affect the ability to drive vehicles and engage in other activities requiring increased concentration and speed of psychomotor reactions.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer
Mildronate capsules 500mg, 90pcs
OKI, sachets 80mg 2g, 12pcs
Cavinton Comfort, dispersible pills 10mg 90pcs
Cortexin, 10mg, 5ml, 10pcs
Phenibut-Vertex pills 250mg, 20pcs
Picamilon pills 50mg, 60pcs
Belosalic, ointment, 30g
Kagocel pills 12mg, 30pcs
Actovegin pills 200mg, 50pcs
Fenotropil pills 100mg, 60pcs
Cerebrolysin, solution for injection 2ml ampoules 10pcs
No-spa pills 40mg, 64pcs
Belosalic, lotion solution for external use spray 100ml
Arbidol, capsules 100mg, 40pcs
Ingavirin capsules 90mg, 10pcs
Nootropil pills 800mg, 30pcs 